510(k) K960257

N ANTISERUM TO C1 INHIBITOR by Behring Diagnostics, Inc. — Product Code DBA

K960257 is an FDA 510(k) premarket notification submitted by Behring Diagnostics, Inc. for the device "N ANTISERUM TO C1 INHIBITOR". The FDA issued a decision of Substantially Equivalent on August 1, 1996. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Behring Diagnostics, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 1, 1996
Date Received
January 18, 1996
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5250
Review Panel
IM
Submission Type